2021-01-05,Outlook Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
2020-12-23,Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
2020-12-07,Is OTLK A Good Stock To Buy Now?
2020-12-01,Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
2020-11-19,Outlook Therapeutics Announces Creation of Global Retina Advisory Council
2020-11-11,"Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed wet AMD Treatment Landscape and ONS-5010/LYTENAVA"
2020-11-05,Outlook Therapeutics Secures $10 Million in Additional Working Capital
2020-11-03,Outlook Therapeutics Completes Patient Enrollment of Open-Label Safety Study for ONS-5010/LYTENAVA (bevacizumab-vikg)
2020-10-22,Outlook Therapeutics to Present at the Virtual Investor KOL Roundtable
2020-10-13,Outlook Therapeutics Announces Initiation of Supplemental Open-Label Safety Study for ONS-5010 / LYTENAVA (bevacizumab-vikg)
2020-10-12,"These 2 Penny Stocks Could See Outsized Gains, Says Oppenheimer"
2020-10-07,Outlook Therapeutics to Present at the Virtual BIO Investor Forum Digital
2020-09-30,Outlook Therapeutics Provides Update on Progress Towards First Approved Ophthalmic Formulation of Bevacizumab-vikg for Advanced Macular Degeneration
2020-09-08,Outlook Therapeutics to Present at Two Upcoming Investor Conferences
2020-08-26,"When Can We Expect A Profit From Outlook Therapeutics, Inc. (NASDAQ:OTLK)?"
2020-08-26,Outlook Therapeutics Reports Topline Results and Positive Proof-of-Concept for ONS-5010 / LYTENAVA (bevacizumab-vikg) from NORSE 1
2020-08-14,Outlook Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2020 and Provides Corporate Update
2020-07-17,Outlook Therapeutics Announces Closing of $1.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2020-07-07,Outlook Therapeutics Completes Patient Enrollment for NORSE 2 Study of ONS-5010 / LYTENAVA (bevacizumab-vikg)
2020-06-25,Outlook Therapeutics (OTLK) Catches Eye: Stock Jumps 7%
2020-06-25,Outlook Therapeutics Announces Closing of $10.2 Million Financing Priced At-The-Market Under Nasdaq Rules
2020-06-23,Outlook Therapeutics Announces $11.2 Million Financings Priced At-The-Market Under Nasdaq Rules
2020-06-17,Outlook Therapeutics Provides Clinical Update on ONS-5010 / LYTENAVA (bevacizumab-vikg)
2020-06-11,Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
2020-06-10,"Is Outlook Therapeutics, Inc. (OTLK) A Good Stock To Buy?"
2020-06-09,Outlook Therapeutics to Present at the Virtual Investor Fireside Chat Series
2020-06-03,Outlook Therapeutics Announces Closing of $16.0 Million Private Placement
2020-05-26,Outlook Therapeutics Announces $16.0 Million Private Placement to Advance the Development of ONS-5010 / LYTENAVA (bevacizumab-vikg)
2020-05-20,"Some Analysts Just Cut Their Outlook Therapeutics, Inc. (NASDAQ:OTLK) Estimates"
2020-05-15,Outlook Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2020 and Provides Corporate Update
2020-04-21,Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors
2020-04-16,Outlook Therapeutics (OTLK) Catches Eye: Stock Jumps 7.6%
2020-04-15,Outlook Therapeutics to Present at the April 2020 Virtual Investor Summit
2020-04-14,Outlook Therapeutics Provides COVID-19 Impact Update on Ongoing Clinical Trials NORSE 1 and NORSE 2
2020-03-19,Investors Who Bought Outlook Therapeutics (NASDAQ:OTLK) Shares Three Years Ago Are Now Down 98%
2020-03-05,"Outlook Therapeutics Announces LYTENAVA (bevacizumab-vikg), Anticipated Brand Name for ONS-5010, If Approved"
2020-02-26,Outlook Therapeutics Announces Closing of $10.2 Million Financings Priced At-The-Market
2020-02-25,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Outlook Therapeutics, Inc.-OTLK"
2020-02-24,Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market
2020-02-18,"INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Outlook Therapeutics, Inc. for Potential Securities Violations and Breach of Fiduciary Duty Claims."
2020-02-14,Outlook Therapeutics Provides Business Update and Reports Financial Results for the First Quarter of Fiscal Year 2020
2020-02-04,Outlook Therapeutics to Present at the 2020 BIO CEO & Investor Conference
2020-01-28,Outlook Therapeutics Announces Agreements to Streamline Capital Structure and Regain 100% Ownership of Any Future Net Profits for ONS-5010
2019-12-26,Outlook Therapeutics Announces Completion of Warrant Restructuring
2019-12-24,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict"
2019-12-23,Outlook Therapeutics Announces Warrant Amendment and Restructuring of Senior Secured Notes in Separate Transactions
2019-12-19,Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2019
2019-12-03,Outlook Therapeutics Receives FDA Agreement for Three Special Protocol Assessments for Additional Planned Clinical Trials of ONS-5010
2019-11-13,"What Kind Of Shareholders Own Outlook Therapeutics, Inc. (NASDAQ:OTLK)?"
2019-09-11,Outlook Therapeutics to Present at the 29th Annual Ladenburg Thalmann 2019 Healthcare Conference
2019-08-27,Outlook Therapeutics to Present at the H.C. Wainwright 21st Annual Healthcare Conference
2019-08-20,Outlook Therapeutics Completes Patient Enrollment for NORSE 1 a Phase 3 Clinical Trial for ONS-5010 in Wet AMD
2019-08-14,Outlook Therapeutics Provides Business Update and Reports Financial Results for Third Quarter of Fiscal 2019
2019-07-19,"A Look At Benzinga Pro's Most-Searched Tickers For July 19, 2019"
2019-07-18,"A Look At Benzinga Pro's Most-Searched Tickers For July 18, 2019"
2019-07-16,Outlook Therapeutics Doses First Patient in the Second Phase 3 Clinical Trial for ONS-5010 in Wet AMD
2019-06-03,"Hottest Wall Street Stories: What's Up, What's Down"
2019-06-03,Outlook Therapeutics Signs Manufacturing Supply Agreement with FUJIFILM Diosynth Biotechnologies as Part of Commercialization Strategy for ONS-5010
2019-05-24,A Look At Benzinga Pro's Most-Searched Tickers For May 24
2019-05-20,"Outlook Therapeutics stock rockets on heavy volume again, set to triple in 3 days"
2019-05-17,Outlook Therapeutics Rallies 150% In 2 Days: What You Need To Know
2019-05-17,"Outlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 days"
2019-05-16,Outlook Therapeutics started at outperform with $12 stock price target at Oppenheimer
2019-05-15,Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019
2019-04-26,"Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development"
2019-04-10,Outlook Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
2019-04-01,Outlook Therapeutics Announces FDA Acceptance of IND for ONS-5010
2019-03-15,Outlook Therapeutics Announces Reverse Stock Split
2019-03-05,Outlook Therapeutics Regains Compliance With All Nasdaq Listing Requirements
2019-03-01,Outlook Therapeutics Submits IND Application for ONS-5010 to the FDA
2019-02-14,Outlook Therapeutics Provides Business Update and Reports First Quarter Financial Results for Fiscal 2019
2019-02-13,Healthcare Investment Opportunities You Can't Miss
2019-02-01,Outlook Therapeutics Closes Final Tranche of $20 Million Private Placement
2019-01-22,Outlook Therapeutics Announces Exercise Price Reduction and Term Extension of Series A Warrants
2019-01-02,Outlook Therapeutics Closes Third Tranche of $20 Million Private Placement
2018-12-18,Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2018
